- Jason Bond Picks (Member)
- Posts
- Fibonacci setups
*together with Prosperity Pub
You Must Have Missed This, Right?
AI-Powered “Buy” and “Sell” Signals On Your Favorite Trades.
If You’re Unhappy (doubtful), Get Every Penny Back.
Good morning,
IWM is getting destroyed but we expect that right now.
Focus on the momentum stocks and true penny stocks as those will be immune, to a large degree.
ICCT, CTOR, and TGL are some true penny stocks that are on fire this morning. I’ll look for bull flags on these in the afternoon and alert if they are setup for gaps.
XOS spiked Friday night after announcing highest ever gross profit. I’m trading this one Monday morning — and if it goes over $4 there’s some range.
DOMH is a news winner this morning and has good range above if it can hold $6. Range is around $10 if this explodes like it did in February.
TNON is another Fibonacci retracement trade I started in on Friday looking for the squeeze. It’s in play above $2 with range to middle $3’s if it works. I’m long TNON already.
WHLR is a split and squeeze penny stock I like. In the low $3’s I could see this popping into the $4’s.
LQMT is a long-term trade I’m in. Over the weekend a lot more hinge videos came out. I thought this one describes the catalyst the best.
Here’s how I see all of this. About seven years ago, I subscribed to a newsletter called BiotechRunup, led by a pharmacist who was also the main trader. The strategy was simple but smart: buy biotech stocks six months to a year before their PDUFA dates—the FDA’s target date for deciding on a company’s new drug application. These companies often had zero revenue, but as the decision date approached, their stock prices would typically climb sharply in anticipation.
In my opinion, this approach made a lot of sense. It wasn’t just a typical stock move—it felt more like betting on a potential moonshot.
Now, I’m seeing a parallel with LQMT and Apple. In this case, the “FDA approval” moment is Apple’s product launch. And I think the hype is real—it’s still early, and momentum is building fast, as more media outlets start covering it. If Apple really has a foldable device where the hinge doesn't degrade and the crease is practically invisible, that’s a massive breakthrough—something no one else has pulled off.
It's like a new drug targeting a major illness: the potential is huge. Even the runup to the launch could be a game changer for Apple’s stock.
Disclosure: I am long LQMT stock and buy / sell without notice.
Eat. Sleep. & Trade!
Jason Bond
Questions or concerns about our products? Email [email protected]
© Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer.
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.